Income Statement Wow Factor Thailand S.E.

Stocks

XBIO-R

TH0753010R12

Financial & Commodity Market Operators

End-of-day quote Thailand S.E. 2026-08-14			5-day change	1st Jan Change
0.0700 ^THB	-12.50%		-12.50%	-58.82%

07-20	X Bioscience Reports Higher Impairment Charges in Q1	MT
07-16	X Bioscience Public Company Limited Announces CEO Changes	CI

6caf6de151f1c37564e314818673.m9D0XEQDOl100-bgKH8ya7qHkSaLbRv1vf5biRNFedQ.zb-VDDRKXm4f5YPVHE52Xv6qwmzqCGiMxJgc4iE0Mo73iYU9A0RwExa41g

Published financial data: WOW FACTOR

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	412M	344M	312M	319M	130M
Total Revenues	412M	344M	312M	319M	130M
Cost of Goods Sold, Total	219M	172M	160M	181M	76.61M
Gross Profit	193M	172M	152M	139M	53.04M
Selling General & Admin Expenses, Total	472M	274M	273M	390M	507M
Provision for Bad Debts	-	-	-	-	-
Other Operating Expenses, Total	472M	274M	273M	390M	507M
Operating Income	-279M	-102M	-120M	-251M	-454M
Interest Expense, Total	-16.78M	-56.52M	-39.94M	-34.29M	-26.22M
Interest And Investment Income	10.09K	13.88K	-	-	-
Net Interest Expenses	-16.77M	-56.5M	-39.94M	-34.29M	-26.22M
Currency Exchange Gains (Loss)	-320K	-	-	-	-
Other Non Operating Income (Expenses)	13.76M	3.32M	11.72M	7.58M	6.26M
EBT, Excl. Unusual Items	-282M	-155M	-149M	-278M	-474M
Impairment of Goodwill	-	-80.6M	-	-	-
Gain (Loss) On Sale Of Investments	-	-	-	-	-
Gain (Loss) On Sale Of Assets	-	-101M	-	-	18.53M
Asset Writedown	-	-	-	-	-
EBT, Incl. Unusual Items	-282M	-336M	-149M	-278M	-456M
Income Tax Expense	-5.65M	-5.65M	-1.13M	-15.84M	-3.25M
Earnings From Continuing Operations	-276M	-331M	-148M	-262M	-452M
Earnings Of Discontinued Operations	-	-245M	-	-	-16.94M
Net Income to Company	-276M	-576M	-148M	-262M	-469M
Minority Interest	-	-	-	1.85M	570K
Net Income - (IS)	-276M	-576M	-148M	-260M	-469M
Net Income to Common Incl Extra Items	-276M	-576M	-148M	-260M	-469M
Net Income to Common Excl. Extra Items	-276M	-331M	-148M	-260M	-452M
Per Share Items
Net EPS - Basic	-2.38	-4.95	-1.18	-1.41	-1.17
Basic EPS - Continuing Operations	-2.38	-2.84	-1.18	-1.41	-1.13
Basic Weighted Average Shares Outstanding	116M	116M	125M	184M	402M
Net EPS - Diluted	-2.38	-4.95	-1.18	-1.41	-1.17
Diluted EPS - Continuing Operations	-2.38	-2.84	-1.18	-1.41	-1.13
Diluted Weighted Average Shares Outstanding	116M	116M	125M	184M	402M
Normalized Basic EPS	-1.52	-0.83	-0.74	-0.93	-0.74
Normalized Diluted EPS	-1.52	-0.83	-0.74	-0.93	-0.74
American Depositary Receipts Ratio (ADR)	1	1	1	1	1
Supplemental Items
EBITDA	-192M	-8.12M	-103M	-225M	-436M
EBITA	-227M	-53.51M	-120M	-247M	-454M
EBIT	-279M	-102M	-120M	-251M	-454M
EBITDAR	-152M	-	-101M	-221M	-435M
Total Revenues (As Reported)	-	-	-	-	-
Effective Tax Rate - (Ratio)	2	1.68	0.76	5.7	0.71
Total Current Taxes	-	-	-	-	-
Deferred Domestic Taxes	-5.65M	-	-	-	-
Total Deferred Taxes	-5.65M	-5.65M	-1.13M	-15.84M	-3.25M
Normalized Net Income	-176M	-96.94M	-92.91M	-172M	-296M
Interest on Long-Term Debt	-	-	5.81M	6.89M	4.24M
Non-Cash Pension Expense	-	-	58.14K	-	-
Supplemental Operating Expense Items
Selling and Marketing Expenses	281M	155M	156M	167M	77.06M
General and Administrative Expenses	191M	119M	117M	223M	430M
Net Rental Expense, Total	39.78M	-	1.26M	3.39M	1.15M
Imputed Operating Lease Interest Expense	15.93M	-	903K	2.42M	810K
Imputed Operating Lease Depreciation	23.86M	-	352K	973K	339K

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	28.01M	16.16M	26.75M	9.19M	1.57M
Short Term Investments	-	-	-	-	3.09M
Total Cash And Short Term Investments	28.01M	16.16M	26.75M	9.19M	4.66M
Accounts Receivable, Total	5.07M	3.71M	587K	34.63M	251K
Other Receivables	18.19M	14.12M	28.56M	15.6M	10.86M
Notes Receivable	-	-	-	-	-
Total Receivables	23.26M	17.83M	29.15M	50.23M	11.11M
Inventory	35.12M	13.09M	6.76M	11.87M	2.22M
Prepaid Expenses	3.28M	1.54M	1.43M	3.19M	701K
Other Current Assets, Total	9.8M	6.51M	7.09M	32.69M	283M
Total Current Assets	99.47M	55.12M	71.19M	107M	302M
Gross Property Plant And Equipment	458M	258M	304M	744M	142M
Accumulated Depreciation	-163M	-84.91M	-90.49M	-148M	-43.46M
Net Property Plant And Equipment	295M	174M	214M	596M	98.72M
Goodwill	516M	267M	246M	335M	123M
Other Intangibles, Total	365M	150M	147M	319M	70.86M
Deferred Tax Assets Long-Term	-	-	-	134K	-
Other Long-Term Assets, Total	45.55M	53.92M	61.6M	56.17M	14.63M
Total Assets	1.32B	700M	739M	1.41B	609M
Liabilities
Accounts Payable, Total	71.01M	29.54M	28.22M	46.65M	38.44M
Accrued Expenses, Total	17.5M	25.24M	38.33M	39.3M	45.45M
Short-term Borrowings	302M	340M	293M	252M	183M
Current Portion of Long-Term Debt	3.14M	3.21M	3.05M	3.05M	2.93M
Current Portion of Leases	30.18M	27.23M	26.64M	22.16M	14.64M
Current Income Taxes Payable	-	-	-	-	-
Unearned Revenue Current, Total	299K	377K	1.68M	6.12M	369K
Other Current Liabilities	28.05M	31.17M	35.02M	64.14M	40.77M
Total Current Liabilities	452M	457M	426M	433M	326M
Long-Term Debt	13.2M	10.68M	8.29M	5.93M	3.71M
Long-Term Leases	121M	91.51M	83.81M	71.57M	35.86M
Unearned Revenue Non Current	-	-	-	-	-
Pension & Other Post Retirement Benefits	6.95M	2.3M	3.25M	5.4M	6.59M
Deferred Tax Liability Non Current	34.65M	29.01M	27.88M	64.88M	10.61M
Other Non Current Liabilities	19.66M	6.94M	7.15M	5.88M	3.53M
Total Liabilities	647M	598M	557M	587M	386M
Common Stock, Total	814M	814M	1.03B	1.94B	7.35B
Additional Paid In Capital	-	-	-	-	-
Retained Earnings	-398M	-969M	-1.12B	-1.38B	-1.85B
Comprehensive Income and Other	257M	257M	269M	-53.66M	-5.29B
Total Common Equity	673M	103M	183M	514M	217M
Minority Interest	2.78K	2.7K	2.7K	314M	6.58M
Total Equity	673M	103M	183M	827M	223M
Total Liabilities And Equity	1.32B	700M	739M	1.41B	609M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	116M	116M	147M	278M	1.05B
ECS Total Common Shares Outstanding	116M	116M	147M	278M	1.05B
Book Value / Share	5.79	0.88	1.24	1.85	0.21
Tangible Book Value	-208M	-315M	-210M	-141M	22.37M
Tangible Book Value Per Share	-1.79	-2.71	-1.43	-0.51	0.02
Total Debt	469M	473M	415M	355M	240M
Net Debt	441M	457M	388M	345M	236M
Debt Equivalent of Unfunded Proj. Benefit Obligation	7.58M	2.3M	3.25M	5.4M	6.59M
Debt Equivalent Oper. Leases	318M	-	10.04M	27.11M	9.19M
Minority Interest, Total (Incl. Fin. Div)	2.78K	2.7K	2.7K	314M	6.58M
Account Code - Inventory Valuation	5	5	5	5	5
Inventories - Raw Materials, Total	24.98M	5.54M	4.09M	6.62M	2.15M
Inventories - Work In Process, Total	-	-	-	-	-
Inventories - Finished Goods, Total	5.36M	6.14M	1.84M	4.59M	71.82K
Inventories - Others	4.77M	1.41M	837K	667K	-
Land - (BS)	-	-	-	126M	-
Buildings, Total	-	-	-	-	63.21M
Machinery, Total	123M	72.44M	70.33M	354M	30.9M
Accumulated Allowance for Doubtful Accounts (Supple)	-	-	-	-	-

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	-276M	-576M	-148M	-260M	-469M
Depreciation & Amortization - CF	67.37M	95.55M	45.13M	61.5M	36.39M
Amortization of Goodwill and Intangible Assets - (CF)	51.42M	48.4M	901K	3.85M	557K
Depreciation & Amortization, Total	119M	144M	46.04M	65.35M	36.94M
Amortization of Deferred Charges, Total - (CF)	1.28M	2.27M	569K	1.94M	3.12M
(Gain) Loss From Sale Of Asset	262K	98.28M	4.29K	-297K	169M
(Gain) Loss on Sale of Investments - (CF)	-	-	-	-	15.25M
Asset Writedown & Restructuring Costs	4.52M	86.78M	25.06M	100M	110M
Provision and Write-off of Bad Debts	-	-	-	6.99M	-
Net Cash From Discontinued Operations	-	-245M	-	-	-
Other Operating Activities, Total	13.27M	256M	8.22M	-11.03M	46.72M
Change In Accounts Receivable	-10.28M	-9.72M	-2.81M	21.17M	-953K
Change In Inventories	-14.88M	-6.61M	6.33M	-4.5M	3.87M
Change In Accounts Payable	35.27M	100M	-4.13M	38.31M	-4.3M
Change in Other Net Operating Assets	-10.82M	-2.16M	-8.06M	4.64M	13.67M
Cash from Operations	-139M	-152M	-76.31M	-37.44M	-75.29M
Capital Expenditure	-73.43M	-139M	-57.28M	-36.33M	-3.59M
Sale of Property, Plant, and Equipment	60.75K	3.51M	4.1M	2.11M	1.41M
Cash Acquisitions	-	-	-	-445M	-
Divestitures	-	267M	-	-	14.79M
Investment in Marketable and Equity Securities, Total	-	-	-	-	-
Net (Increase) Decrease in Loans Originated / Sold - Investing	-	-	-	-	-
Other Investing Activities, Total	-600K	-200K	-	-250K	-122K
Cash from Investing	-73.97M	132M	-53.18M	-479M	12.49M
Short Term Debt Issued, Total	295M	517M	260M	28.06M	53.07M
Long-Term Debt Issued, Total	6M	-	-	-	-
Total Debt Issued	301M	517M	260M	28.06M	53.07M
Short Term Debt Repaid, Total	-66.49M	-456M	-311M	-76.9M	-123M
Long-Term Debt Repaid, Total	-36.49M	-59.14M	-36.93M	-42.64M	-31M
Total Debt Repaid	-103M	-515M	-348M	-120M	-154M
Issuance of Common Stock	372	-	228M	591M	172M
Other Financing Activities, Total	-	6.9M	-	-	-16.16M
Cash from Financing	198M	8.99M	140M	499M	55.18M
Foreign Exchange Rate Adjustments	-	-	-	-	-
Net Change in Cash	-15.4M	-11.86M	10.59M	-17.56M	-7.62M
Supplemental Items
Cash Interest Paid	3.55M	48.17M	30.47M	18.99M	16.16M
Cash Income Tax Paid (Refund)	-	-	-	-	-
Levered Free Cash Flow	-114M	-89.66M	-99.45M	-148M	-533M
Unlevered Free Cash Flow	-104M	-54.34M	-74.48M	-127M	-516M
Change In Net Working Capital	-24.04M	-1.96M	-11.46M	608K	269M
Net Debt Issued / Repaid	198M	2.09M	-87.69M	-91.48M	-101M

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	-13.4	-6.3	-10.46	-14.58	-28.06
Return on Total Capital	-15.2	-7.42	-12.83	-17.64	-34.51
Return On Equity %	-34.1	-85.25	-103.4	-51.88	-86.14
Return on Common Equity	-34.1	-85.26	-103.4	-74.74	-123.79
Margin Analysis
Gross Profit Margin %	46.9	49.98	48.79	43.42	40.91
SG&A Margin	114.49	79.57	87.41	122.11	391.31
EBITDA Margin %	-46.48	-2.36	-32.94	-70.33	-336.59
EBITA Margin %	-55.12	-15.53	-38.34	-77.48	-349.97
EBIT Margin %	-67.59	-29.58	-38.63	-78.69	-350.4
Income From Continuing Operations Margin %	-67.03	-96.02	-47.32	-82.09	-349
Net Income Margin %	-67.03	-167.2	-47.32	-81.51	-361.63
Net Avail. For Common Margin %	-67.03	-96.02	-47.32	-81.51	-348.56
Normalized Net Income Margin	-42.75	-28.14	-29.8	-53.83	-228.18
Levered Free Cash Flow Margin	-27.65	-26.03	-31.9	-46.39	-410.99
Unlevered Free Cash Flow Margin	-25.11	-15.77	-23.89	-39.67	-398.35
Asset Turnover
Asset Turnover	0.32	0.34	0.43	0.3	0.13
Fixed Assets Turnover	1.58	1.47	1.61	0.79	0.37
Receivables Turnover (Average Receivables)	93.99	78.5	145.16	18.13	9.3
Inventory Turnover (Average Inventory)	7.91	7.15	16.08	19.39	10.88
Short Term Liquidity
Current Ratio	0.22	0.12	0.17	0.25	0.93
Quick Ratio	0.11	0.07	0.13	0.14	0.05
Operating Cash Flow to Current Liabilities	-0.31	-0.33	-0.18	-0.09	-0.23
Days Sales Outstanding (Average Receivables)	3.88	4.65	2.51	20.19	39.27
Days Outstanding Inventory (Average Inventory)	46.12	51.06	22.69	18.88	33.56
Average Days Payable Outstanding	83.13	122.11	68.74	73.76	231.88
Cash Conversion Cycle (Average Days)	-33.12	-66.4	-43.53	-34.69	-159.05
Long Term Solvency
Total Debt/Equity	69.65	461.24	227.04	42.85	107.69
Total Debt / Total Capital	41.06	82.18	69.42	30	51.85
LT Debt/Equity	19.93	99.65	50.38	9.37	17.73
Long-Term Debt / Total Capital	11.75	17.76	15.41	6.56	8.54
Total Liabilities / Total Assets	49.01	85.35	75.28	41.5	63.37
EBIT / Interest Expense	-16.61	-1.8	-3.01	-7.33	-17.33
EBITDA / Interest Expense	-9.53	0.74	-1.86	-5.42	-15.92
(EBITDA - Capex) / Interest Expense	-13.91	-1.71	-3.3	-6.48	-16.05
Total Debt / EBITDA	-2.93	11.25	-5.58	-1.91	-0.58
Net Debt / EBITDA	-2.76	10.87	-5.22	-1.86	-0.56
Total Debt / (EBITDA - Capex)	-2.01	-4.89	-3.15	-1.6	-0.57
Net Debt / (EBITDA - Capex)	-1.89	-4.72	-2.95	-1.55	-0.56
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-0.76	35.6	-9.5	2.4	-59.39
Gross Profit, 1 Yr. Growth %	49.24	35.34	-11.66	-8.87	-61.73
EBITDA, 1 Yr. Growth %	192.38	-39.88	-45.79	118.65	94.36
EBITA, 1 Yr. Growth %	125.52	8.89	-49.1	106.96	83.43
EBIT, 1 Yr. Growth %	111.77	1.35	-57.48	108.6	80.85
Earnings From Cont. Operations, 1 Yr. Growth %	16.58	231.1	-55.4	77.65	72.66
Net Income, 1 Yr. Growth %	15.76	108.35	-74.39	76.4	80.18
Normalized Net Income, 1 Yr. Growth %	102.29	46.95	-55.81	84.97	72.15
Diluted EPS Before Extra, 1 Yr. Growth %	-3.36	231.1	-58.62	20.09	-20.41
Accounts Receivable, 1 Yr. Growth %	36.64	-26.82	-84.17	5.8K	-99.09
Inventory, 1 Yr. Growth %	73.55	-62.72	-48.32	75.46	-81.3
Net Property, Plant and Equip., 1 Yr. Growth %	30.3	-41.09	23.23	178.81	-83.44
Total Assets, 1 Yr. Growth %	3.13	-46.99	5.61	91.29	-56.92
Tangible Book Value, 1 Yr. Growth %	-1.28K	51.75	-33.35	-32.8	-115.86
Common Equity, 1 Yr. Growth %	-28.97	-84.77	78.27	180.91	-57.82
Cash From Operations, 1 Yr. Growth %	361.73	9.54	-49.93	-50.93	306.68
Capital Expenditures, 1 Yr. Growth %	95.99	89.04	-58.74	-36.58	-90.11
Levered Free Cash Flow, 1 Yr. Growth %	-148.66	7.3K	-51.01	48.9	387.47
Unlevered Free Cash Flow, 1 Yr. Growth %	-142.32	-795.13	-55.57	70.04	487.71
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-1.45	-8.96	10.78	-3.73	-35.51
Gross Profit, 2 Yr. CAGR %	15.44	15.25	9.34	-10.28	-40.95
EBITDA, 2 Yr. CAGR %	230.63	-64.8	175.66	8.87	106.15
EBITA, 2 Yr. CAGR %	94.67	-27.14	55.95	2.64	94.84
EBIT, 2 Yr. CAGR %	84.26	-12.01	9.43	-5.82	94.23
Earnings From Cont. Operations, 2 Yr. CAGR %	255.42	18.11	21.52	-10.99	75.14
Net Income, 2 Yr. CAGR %	255.42	55.3	-26.95	-32.78	78.28
Normalized Net Income, 2 Yr. CAGR %	76.66	5.46	18.67	-9.59	78.45
Diluted EPS Before Extra, 2 Yr. CAGR %	236.48	7.53	17.05	-29.51	-2.24
Accounts Receivable, 2 Yr. CAGR %	-77.22	-0	-65.97	205.59	-34.65
Inventory, 2 Yr. CAGR %	-36.22	-19.57	-56.11	-4.78	-42.72
Net Property, Plant and Equip., 2 Yr. CAGR %	7.13	-12.39	-14.8	85.36	-32.06
Total Assets, 2 Yr. CAGR %	2.54	-26.06	-25.17	42.14	-9.22
Tangible Book Value, 2 Yr. CAGR %	-4.64	322.62	0.57	-33.08	-67.35
Common Equity, 2 Yr. CAGR %	-7.57	-67.11	-47.9	123.78	8.86
Cash From Operations, 2 Yr. CAGR %	108.3	124.97	-25.94	-50.43	-0.67
Capital Expenditures, 2 Yr. CAGR %	5.43	92.48	-11.68	-48.84	-74.96
Levered Free Cash Flow, 2 Yr. CAGR %	3.87	-38.15	806.04	-14.59	131.48
Unlevered Free Cash Flow, 2 Yr. CAGR %	1.37	-52.88	208.68	-13.09	163.33
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	11.44	-6.74	-9.14	7.91	-27.8
Gross Profit, 3 Yr. CAGR %	30.44	5.86	5.48	2.9	-32.46
EBITDA, 3 Yr. CAGR %	54.19	-22.62	16.13	155.17	32.07
EBITA, 3 Yr. CAGR %	145.1	-3.74	5.84	71.38	24.55
EBIT, 3 Yr. CAGR %	162.75	7.47	-2.92	35.69	17.06
Earnings From Cont. Operations, 3 Yr. CAGR %	275.24	147.24	-14.63	37.92	11.01
Net Income, 3 Yr. CAGR %	275.24	197.46	-14.83	-2	-6.63
Normalized Net Income, 3 Yr. CAGR %	170.54	19.72	2.15	37.6	12.06
Diluted EPS Before Extra, 3 Yr. CAGR %	124.55	138.38	-21.79	18.06	-26.6
Accounts Receivable, 3 Yr. CAGR %	-59.06	-66.39	-45.91	89.77	-59.26
Inventory, 3 Yr. CAGR %	-20.48	-46.68	-30.6	-30.34	-44.65
Net Property, Plant and Equip., 3 Yr. CAGR %	-7.38	-12.23	-1.84	26.49	-17.15
Total Assets, 3 Yr. CAGR %	19.39	-17.7	-16.73	2.31	-4.52
Tangible Book Value, 3 Yr. CAGR %	-26.22	11.33	128.34	-12.08	-58.58
Common Equity, 3 Yr. CAGR %	6.51	-49.33	-42.23	-8.64	28.31
Cash From Operations, 3 Yr. CAGR %	90.1	68.17	36.34	-35.44	-20.95
Capital Expenditures, 3 Yr. CAGR %	31.32	28.08	15.2	-20.91	-70.42
Levered Free Cash Flow, 3 Yr. CAGR %	32.71	-5.34	-24.86	396.29	37.95
Unlevered Free Cash Flow, 3 Yr. CAGR %	32.68	-18.61	-32.73	153.04	45.5
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	17.63	8.43	0.91	-5.55	-20.78
Gross Profit, 5 Yr. CAGR %	37.52	19.59	11.78	-0.92	-16.37
EBITDA, 5 Yr. CAGR %	5.48	-12.53	14.45	66.52	46.09
EBITA, 5 Yr. CAGR %	6.88	70.45	50.58	32.75	35.1
EBIT, 5 Yr. CAGR %	11.09	85.06	50.95	25.06	28.11
Earnings From Cont. Operations, 5 Yr. CAGR %	15.48	20.26	95	64.31	13.8
Net Income, 5 Yr. CAGR %	15.48	34.37	95	64.07	14.45
Normalized Net Income, 5 Yr. CAGR %	14.75	49.82	59.84	24.92	27.69
Diluted EPS Before Extra, 5 Yr. CAGR %	-35.09	-22.2	41.16	46.43	-14.49
Accounts Receivable, 5 Yr. CAGR %	-35.7	-44.5	-61.98	-18.72	-41.66
Inventory, 5 Yr. CAGR %	-10.44	-28.26	-37.31	-32.76	-35.72
Net Property, Plant and Equip., 5 Yr. CAGR %	22.32	-11.06	-10.42	18.36	-15.28
Total Assets, 5 Yr. CAGR %	27.81	-2.94	-0.96	2.4	-13.8
Tangible Book Value, 5 Yr. CAGR %	-7.84	-9.24	-16.48	-9.18	4.88
Common Equity, 5 Yr. CAGR %	16.57	-28.59	-19.98	-8.21	-25.57
Cash From Operations, 5 Yr. CAGR %	34.47	77.71	30.4	3.16	20.11
Capital Expenditures, 5 Yr. CAGR %	44.87	85.61	12.05	-11.27	-37.44
Levered Free Cash Flow, 5 Yr. CAGR %	7.72	25.44	15.3	6.97	17.85
Unlevered Free Cash Flow, 5 Yr. CAGR %	6	15.01	10.93	4.68	16.11